Andreas it is from here:...

Andreas it is from here: http://www.prnewswire.com/news-releases/lilly-to-acquire-global-license-to-axiron-testosterone-solution-from-acrux-87688197.html

So the terms (subject to ACR's confirmation) are:

-$50 million down payment
-$3 million on the transfer of manufacturing assets

Further eligible for
-$87 million upon the issuance of marketing authorization by the FDA
-up to $195 million in potential commercialization milestones
-royalty payments on future global sales if AXIRON is successfully commercialized

So a US$335m+ deal. Representing over $2/share!